Want to see JP:4598 full AI Analyst Report?

Delta-Fly Pharma, Inc. (4598) Ratios

1 Followers

Delta-Fly Pharma, Inc. Ratios

JP:4598's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4598's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 26	Mar 25	Mar 24
Liquidity Ratios
Current Ratio	―	2.52	0.98	5.93	7.49
Quick Ratio	―	2.52	0.98	5.93	7.49
Cash Ratio	―	2.16	0.68	5.87	7.30
Solvency Ratio	―	-10.99	-7.64	-5.91	-11.48
Operating Cash Flow Ratio	―	-11.72	-7.32	-5.30	-11.27
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	¥ ―	¥ 238.14M	¥ -4.75M	¥ 1.19B	¥ 750.60M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.56	7.26	1.20	1.15
Debt Service Coverage Ratio	―	0.00	0.00	0.00	0.00
Interest Coverage Ratio	―	0.00	0.00	0.00	0.00
Debt to Market Cap	―	0.00	0.00	0.00	0.00
Interest Debt Per Share	―	0.00	0.00	0.00	0.00
Net Debt to EBITDA	―	0.20	0.09	1.01	0.64
Profitability Margins
Gross Profit Margin	―	0.00%	0.00%	0.00%	0.00%
EBIT Margin	―	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	―	0.00%	0.00%	0.00%	0.00%
Operating Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Pretax Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Continuous Operations Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Income Per EBT	―	100.15%	100.15%	100.18%	100.23%
EBT Per EBIT	―	100.61%	101.14%	101.67%	100.76%
Return on Assets (ROA)	―	-396.28%	-659.16%	-96.96%	-146.53%
Return on Equity (ROE)	―	-619.58%	-4785.01%	-115.96%	-167.95%
Return on Capital Employed (ROCE)	―	-614.92%	-4723.63%	-113.86%	-166.31%
Return on Invested Capital (ROIC)	―	-614.92%	-4723.63%	-113.86%	-166.31%
Return on Tangible Assets	―	-396.28%	-659.16%	-96.96%	-146.53%
Earnings Yield	―	-34.01%	-72.03%	-33.02%	-38.95%
Efficiency Ratios
Receivables Turnover	―	0.00	0.00	0.00	0.00
Payables Turnover	―	0.00	0.00	0.00	0.00
Inventory Turnover	―	0.00	0.00	0.00	0.00
Fixed Asset Turnover	―	0.00	0.00	0.00	0.00
Asset Turnover	―	0.00	0.00	0.00	0.00
Working Capital Turnover Ratio	―	0.00	0.00	0.00	0.00
Cash Conversion Cycle	―	0.00	0.00	0.00	0.00
Days of Sales Outstanding	―	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	―	0.00	0.00	0.00	0.00
Days of Payables Outstanding	―	0.00	0.00	0.00	0.00
Operating Cycle	―	0.00	0.00	0.00	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	-208.47	-134.50	-177.95	-229.97
Free Cash Flow Per Share	―	-208.48	-134.50	-178.11	-230.02
CapEx Per Share	―	0.01	0.00	0.16	0.06
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	―	-15.82K	0.00	-1.13K	-4.06K
Capital Expenditure Coverage Ratio	―	-15.82K	0.00	-1.13K	-4.06K
Operating Cash Flow Coverage Ratio	―	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.00	0.00
Free Cash Flow Yield	―	-36.26%	-68.97%	-29.59%	-38.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-2.94	-1.39	-3.03	-2.57
Price-to-Sales (P/S) Ratio	―	0.00	0.00	0.00	0.00
Price-to-Book (P/B) Ratio	―	18.22	66.43	3.51	4.31
Price-to-Free Cash Flow (P/FCF) Ratio	―	-2.76	-1.45	-3.38	-2.62
Price-to-Operating Cash Flow Ratio	―	-2.76	-1.45	-3.38	-2.62
Price-to-Earnings Growth (PEG) Ratio	―	1.83	0.05	0.20	-0.08
Price-to-Fair Value	―	18.22	66.43	3.51	4.31
Enterprise Value Multiple	―	-2.77	-1.32	-2.08	-1.94
Enterprise Value	―	4.72B	2.11B	2.91B	2.57B
EV to EBITDA	―	-2.77	-1.32	-2.08	-1.94
EV to Sales	―	0.00	0.00	0.00	0.00
EV to Free Cash Flow	―	-2.57	-1.36	-2.27	-1.97
EV to Operating Cash Flow	―	-2.57	-1.36	-2.28	-1.97
Tangible Book Value Per Share	―	31.57	2.94	171.42	139.63
Shareholders’ Equity Per Share	―	31.57	2.94	171.42	139.63
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	>-0.01	>-0.01	>-0.01
Revenue Per Share	―	0.00	0.00	0.00	0.00
Net Income Per Share	―	-195.58	-140.45	-198.78	-234.51
Tax Burden	―	1.00	1.00	1.00	1.00
Interest Burden	―	1.01	1.01	1.02	1.00
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	1.07	0.96	0.90	0.98

Currency in JPY